Figure 1.
Baseline and vasodilator-induced hyperemic (peak) myocardial blood flow (MBF) of the entire left ventricle with Dipyridamole and Regadenoson in patients with hypertrophic cardiomyopathy were very similar
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.